BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18795926)

  • 1. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
    Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
    Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.
    Fargnoli MC; Sera F; Suppa M; Piccolo D; Landi MT; Chiarugi A; Pellegrini C; Seidenari S; Peris K
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1768-75. PubMed ID: 24588892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
    Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
    Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of germline genetic variants on dermoscopic features of melanoma.
    Pozzobon FC; Tell-Marti G; Calbet-Llopart N; Barreiro A; Espinosa N; Potrony M; Alejo B; Podlipnik S; Combalia M; Puig-Butillé JA; Carrera C; Malvehy J; Puig S
    Pigment Cell Melanoma Res; 2021 May; 34(3):618-628. PubMed ID: 33342058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
    Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic study.
    De Giorgi V; Savarese I; D'Errico A; Gori A; Papi F; Colombino M; Sini MC; Stanganelli I; Palmieri G; Massi D
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):574-80. PubMed ID: 25200134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.
    Puig-Butillé JA; Carrera C; Kumar R; Garcia-Casado Z; Badenas C; Aguilera P; Malvehy J; Nagore E; Puig S
    Br J Dermatol; 2013 Oct; 169(4):804-11. PubMed ID: 23647022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
    Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
    Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
    Bassoli S; Maurichi A; Rodolfo M; Casari A; Frigerio S; Pupelli G; Farnetani F; Pelosi G; Santinami M; Pellacani G
    Exp Dermatol; 2013 Jun; 22(6):411-6. PubMed ID: 23711066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
    Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
    Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MC1R variants increase risk of melanomas harboring BRAF mutations.
    Fargnoli MC; Pike K; Pfeiffer RM; Tsang S; Rozenblum E; Munroe DJ; Golubeva Y; Calista D; Seidenari S; Massi D; Carli P; Bauer J; Elder DE; Bastian BC; Peris K; Landi MT
    J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.
    Vallone MG; Tell-Marti G; Potrony M; Rebollo-Morell A; Badenas C; Puig-Butille JA; Gimenez-Xavier P; Carrera C; Malvehy J; Puig S
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):39-50. PubMed ID: 28950052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
    Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
    Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
    Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
    Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
    Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.